Meeting Koch’s postulates for calcium signaling in cardiac hypertrophy
Open Access
- 15 May 2000
- journal article
- review article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 105 (10), 1339-1342
- https://doi.org/10.1172/jci10079
Abstract
No abstract availableThis publication has 65 references indexed in Scilit:
- RXRα overexpression in cardiomyocytes causes dilated cardiomyopathy but fails to rescue myocardial hypoplasia in RXRα-null fetusesJournal of Clinical Investigation, 2000
- A transgenic rabbit model for human hypertrophic cardiomyopathyJournal of Clinical Investigation, 1999
- Signaling Pathways for Cardiac Hypertrophy and FailureNew England Journal of Medicine, 1999
- β-Adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic Gsα mouseJournal of Clinical Investigation, 1999
- Overexpression of nerve growth factor in the heart alters ion channel activity and β‐adrenergic signalling in an adult transgenic mouseThe Journal of Physiology, 1998
- Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy.Journal of Clinical Investigation, 1998
- A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy.Journal of Clinical Investigation, 1998
- The Nuclear δB Isoform of Ca2+/Calmodulin-dependent Protein Kinase II Regulates Atrial Natriuretic Factor Gene Expression in Ventricular MyocytesJournal of Biological Chemistry, 1997
- Cardiac compartment-specific overexpression of a modified retinoic acid receptor produces dilated cardiomyopathy and congestive heart failure in transgenic mice.Journal of Clinical Investigation, 1997
- Genes and physiology: molecular physiology in genetically engineered animals.Journal of Clinical Investigation, 1996